Nuvation Bio

NUVBNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.142 B

$6.10 +0.49%

Close of 22 Sept 2026

Revenue

$62.9M

#2660 by revenue

Earnings

-$204.6M

Loss-making

Shares outstanding

351,123,233

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#103Trevi TherapeuticsTRVI$2.17B
#104Zenas BioPharmaZBIO$2.15B
#105Nuvation BioNUVB$2.14B
#106Braveheart BioBRVE$2.13B
#107UroGen PharmaURGN$2.09B

What if Nuvation Bio were worth as much as…

Open the what-if tool →

Gold $30.2T

$86,106.43

Per share 14,116× higher

Bitcoin $1.74T

$4,960.24

Per share 813× higher

Nvidia $5.52T

$15,708.92

Per share 2,575× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Nuvation Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.